Treatment of ST-segment elevation myocardial infarction during COVID-19 pandemic.

Link to article at PubMed

Icon for Elsevier Science Related Articles

Treatment of ST-segment elevation myocardial infarction during COVID-19 pandemic.

Cardiovasc Revasc Med. 2020 May 21;:

Authors: Yerasi C, Case BC, Forrestal BJ, Chezar-Azerrad C, Hashim H, Ben-Dor I, Satler LF, Mintz GS, Waksman R

Abstract
The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risk and benefits of primary PCI vs. thrombolysis for STEMI. While thrombolysis may seem like a good choice, many patients have a contraindication and could end-up using more resources. Also, with a high probability of the angiogram showing non-obstructed coronary arteries during acute infections, primary PCI should be the preferred strategy.

PMID: 32471712 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.